5,6,7,8-TETRAHYDRO-1,7-NAPHTHYRIDINE, 95.0%, 100mg

1-Eth-1-ynyl-4-(pentyloxy)benzene, 95.0%, 5g

BENZYL 2-ACETYLPHENYLCARBAMATE, 95.0%, 5g

iScope IS.1153-PLPHi Triocular with Plan phase IOS objectives and Rackless cross table (infinity)

(2-Methoxyethyl)triphenylphosphonium bromide, 95.0%, 5g

[(5-fluoro-1H-indol-2-yl)methyl]methylamine sulfate (2:1), 95.0%, 1g

BENZYL (4-METHOXYPHENYL)CARBAMATE, 95.0%, 10g

1-(4-Bromobenzoyl)piperidine, 95.0%, 1g

4-Diphenylmethoxypiperidine hydrochloride, 95.0%, 25g

Methyl 4-amino-3,5-difluorobenzoate, 95.0%, 5g

(1-Methyl-1H-imidazol-5-yl)methylamine, 95.0%, 100mg

2-(2-(2-(2-Chloroethoxy)ethoxy)ethoxy)ethanol, 97%, 5g

1-TERT-BUTYL-1H-[1,2,3]TRIAZOLE-4-CARBALDEHYDE, 97.0%, 1g